← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2016Last known activity
Jan 28, 2018
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 3 trials)
Phase 4 (7 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT03400020Reponsible party - principal investigatorN/AJan 28, 2018
- NCT03400020Study chairN/AJan 28, 2018
- NCT03400020Lead sponsorN/AJan 28, 2018
- NCT02711176Lead sponsorPhase 4Sep 1, 2016
- NCT02711176Overall official - principal investigatorPhase 4Sep 1, 2016
- NCT02885441Lead sponsorPhase 4Sep 1, 2016
- NCT02711176Sponsor investigatorPhase 4Sep 1, 2016
- NCT02885441Reponsible party - principal investigatorPhase 4Sep 1, 2016
Details
- Last known activity
- Jan 28, 2018